3 insiders at Elevance Health Inc. (ELV) reported open-market stock purchases totaling $2,237,800 in recent weeks, according to filings with the U.S. Securities and Exchange Commission. The largest reported purchase came from COLLIS STEVEN H (director), who acquired 3,000 shares at $289.84 on March 05, 2026.
Source: SEC Form 4. Option grants and tax-withholding sales are excluded.
| Date | Insider | Role | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|
| 2026-07-17 | PERU RAMIRO G | director | 1,000 | $366.05 | $366,050 | SEC Form 4 |
| 2026-07-17 | BOUDREAUX GAIL | director, officer: President and CEO | 2,045 | $368.25 | $753,071 | SEC Form 4 |
| 2026-07-17 | BOUDREAUX GAIL | director, officer: President and CEO | 680 | $366.41 | $249,159 | SEC Form 4 |
| 2026-03-05 | COLLIS STEVEN H | director | 3,000 | $289.84 | $869,520 | SEC Form 4 |
Elevance Health Inc. is a Healthcare company in the Medical - Healthcare Plans industry. It carried a market capitalization of about $80.9B, with shares trading near $373.11.
This article is automated factual reporting of public SEC filings, for informational purposes only. It is not investment advice, nor a recommendation, offer or solicitation to buy or sell any security, and reflects no opinion on the company. Figures are drawn from filings believed reliable but are not guaranteed. Always verify against the primary SEC filing and consult a licensed professional. Investing can lose value, up to total loss.